{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:13:41Z","timestamp":1793726021969,"version":"4.6.1"},"reference-count":18,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007059","name":"Northwestern University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007059","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Autoimmunity"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/j.jaut.2021.102629","type":"journal-article","created":{"date-parts":[[2021,3,13]],"date-time":"2021-03-13T21:55:52Z","timestamp":1615672552000},"page":"102629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis"],"prefix":"10.1016","volume":"119","author":[{"given":"Elisa","family":"McEachern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7137-987X","authenticated-orcid":false,"given":"Allison M.","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Fribourg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas D.","family":"Schiano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Hartzell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Bin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Cravedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josh","family":"Levitsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaut.2021.102629_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1056\/NEJMra050408","volume":"354","author":"Krawitt","year":"2006","journal-title":"Autoimmune hepatitis. N Engl J Med"},{"key":"10.1016\/j.jaut.2021.102629_bib2","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1002\/hep.31065","article-title":"Diagnosis and management of autoimmune hepatitis in adults and children: 2019 practice guidance and guidelines from the American association for the study of liver diseases","volume":"72","author":"Mack","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102629_bib3","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102629_bib4","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jhep.2004.03.008","article-title":"Impairment of CD4(+)CD25(+) regulatory T-cells in autoimmune liver disease","volume":"41","author":"Longhi","year":"2004","journal-title":"J. Hepatol."},{"key":"10.1016\/j.jaut.2021.102629_bib5","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1111\/ajt.15369","article-title":"Erythropoietin, a multifaceted protein with innate and adaptive immune modulatory activity","volume":"19","author":"Cantarelli","year":"2019","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jaut.2021.102629_bib6","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1681\/ASN.2013090945","article-title":"Immunosuppressive effects of erythropoietin on human alloreactive T cells","volume":"25","author":"Cravedi","year":"2014","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2021.102629_bib7","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1681\/ASN.2016101100","article-title":"Erythropoietin receptor-mediated molecular crosstalk promotes T cell immunoregulation and transplant survival","volume":"28","author":"Purroy","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2021.102629_bib8","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1681\/ASN.2016101100","article-title":"Erythropoietin receptor-mediated molecular crosstalk promotes T cell immunoregulation and transplant survival","volume":"28","author":"Purroy","year":"2017","journal-title":"J. Am. Soc. Nephrol."},{"key":"10.1016\/j.jaut.2021.102629_bib9","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/j.kint.2019.01.040","article-title":"T-cell exhaustion correlates with improved outcomes in kidney transplant recipients","volume":"96","author":"Fribourg","year":"2019","journal-title":"Kidney Int."},{"key":"10.1016\/j.jaut.2021.102629_bib10","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/cyto.a.22625","article-title":"Using self-organizing maps for visualization and interpretation of cytometry data","volume":"87","author":"Van Gassen","year":"2015","journal-title":"Cytometry"},{"key":"10.1016\/j.jaut.2021.102629_bib11","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1002\/ijc.32782","article-title":"Highly immunosuppressive HLADRhi regulatory T cells are associated with unfavorable outcomes in cervical squamous cell carcinoma","volume":"146","author":"Yang","year":"2020","journal-title":"Int. J. Canc."},{"key":"10.1016\/j.jaut.2021.102629_bib12","article-title":"Erythropoietin inhibits SGK1-dependent TH17 induction and TH17-dependent kidney disease","volume":"5","author":"Donadei","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/j.jaut.2021.102629_bib13","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/nm.4148","article-title":"Low-dose interleukin-2 treatment selectively modulates CD4(+) T cell subsets in patients with systemic lupus erythematosus","volume":"22","author":"He","year":"2016","journal-title":"Nat. Med."},{"key":"10.1016\/j.jaut.2021.102629_bib14","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1002\/hep.30059","article-title":"Low-dose interleukin-2 for refractory autoimmune hepatitis","volume":"68","author":"Lim","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jaut.2021.102629_bib15","doi-asserted-by":"crossref","first-page":"7145","DOI":"10.1038\/s41598-019-43530-x","article-title":"Safety of low-dose subcutaneous recombinant interleukin-2: systematic review and meta-analysis of randomized controlled trials","volume":"9","author":"Mahmoudpour","year":"2019","journal-title":"Sci. Rep."},{"key":"10.1016\/j.jaut.2021.102629_bib16","article-title":"Use of low dose interleukin-2 to expand regulatory T-cells and facilitate the complete discontinuation of immunosuppression in human liver transplantation [abstract]","volume":"19","author":"Lim","year":"2019","journal-title":"Am. J. Transplant."},{"key":"10.1016\/j.jaut.2021.102629_bib17","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41590-018-0120-4","article-title":"Regulatory T cells in autoimmune disease","volume":"19","author":"Dominguez-Villar","year":"2018","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jaut.2021.102629_bib18","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cld.2014.09.004","article-title":"Diagnosis and management of autoimmune hepatitis","volume":"19","author":"Czaja","year":"2015","journal-title":"Clin. Liver Dis."}],"updated-by":[{"DOI":"10.1016\/j.jaut.2021.102665","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000}}],"container-title":["Journal of Autoimmunity"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121000378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0896841121000378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T08:28:34Z","timestamp":1760257714000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0896841121000378"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5]]},"references-count":18,"alternative-id":["S0896841121000378"],"URL":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102629","relation":{},"ISSN":["0896-8411"],"issn-type":[{"value":"0896-8411","type":"print"}],"subject":[],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Erythropoietin administration expands regulatory T cells in patients with autoimmune hepatitis","name":"articletitle","label":"Article Title"},{"value":"Journal of Autoimmunity","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaut.2021.102629","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102629"}}